Caseware UK (AP4) 2025.0.111 2025.0.111 2025-12-31 2025-12-31 true 2025-01-01 true No description of principal activity 0 0 false 04346544 2025-01-01 2025-12-31 04346544 2024-01-01 2024-12-31 04346544 2025-12-31 04346544 2024-12-31 04346544 c:Director1 2025-01-01 2025-12-31 04346544 c:Director3 2025-01-01 2025-12-31 04346544 c:RegisteredOffice 2025-01-01 2025-12-31 04346544 d:CurrentFinancialInstruments 2025-12-31 04346544 d:CurrentFinancialInstruments 2024-12-31 04346544 d:ShareCapital 2025-12-31 04346544 d:ShareCapital 2024-12-31 04346544 c:OrdinaryShareClass1 2025-01-01 2025-12-31 04346544 c:OrdinaryShareClass1 2025-12-31 04346544 c:OrdinaryShareClass1 2024-12-31 04346544 c:EntityHasNeverTraded 2025-01-01 2025-12-31 04346544 c:FRS102 2025-01-01 2025-12-31 04346544 c:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 04346544 c:FullAccounts 2025-01-01 2025-12-31 04346544 c:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 04346544 INSULSLAB LIMITED UNAUDITED DIRECTORS' REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
INSULSLAB LIMITED COMPANY INFORMATION
Directors | Ian Jackson
| Andrew Watkins
Registered number | 04346544
Registered office | Adsetts House
| 16 Europa View
| Sheffield
| S9 1XH
INSULSLAB LIMITED CONTENTS
| Page
Directors' report | 1
Profit and loss account | 2
Balance sheet | 3
Notes to the Financial statements | 4
INSULSLAB LIMITED DIRECTORS' REPORT FOR THE YEAR ENDED 31 DECEMBER 2025 Principal activity The company did not trade in the year and is dormant. The directors present their report and the Financial statements for the year ended 31 December 2025.
Directors' responsibilities statement
The directors are responsible for preparing the Directors' report and the Financial statements in accordance with applicable law and regulations. Company law requires the directors to prepare Financial statements for each financial year. Under that law the directors have elected to prepare the Financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the Financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period. In preparing these Financial statements, the directors are required to: ∙select suitable accounting policies for the Company's financial statements and then apply them consistently; ∙make judgments and accounting estimates that are reasonable and prudent; ∙state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; ∙prepare the Financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business. The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and to enable them to ensure that the Financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Directors
The directors who served during the year and subsequently were:
Ian Jackson Andrew Watkins
This report was approved by the board on 22 April 2026 and signed on its behalf.
Andrew Watkins Director
Page 1
INSULSLAB LIMITED PROFIT AND LOSS ACCOUNT FOR THE YEAR ENDED 31 DECEMBER 2025
The Company has not traded during the year or the preceding financial year. During these periods, the Company received no income and incurred no expenditure and therefore made neither profit or loss.
Page 2
INSULSLAB LIMITED REGISTERED NUMBER: 04346544 BALANCE SHEET AS AT 31 DECEMBER 2025
|  | 2025 |  | 2024
Note |  | £ |  | £
Current assets |  |  |  |  |
Debtors: amounts falling due within one year | 2 | 1,000 |  | 1,000 |
|  | 1,000 |  | 1,000 |
Total assets less current liabilities |  |  | 1,000 |  | 1,000
Net assets |  |  | 1,000 |  | 1,000
Capital and reserves |  |  |  |  |
Called up share capital | 3 |  | 1,000 |  | 1,000
|  |  | 1,000 |  | 1,000
These accounts have been prepared in accordance with the provisions applicable to companies which would be entitled to the small companies' regime but for being a member of an ineligible group. For the year ended 31 December 2025 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006. The members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of Financial statements. The Company was entitled to exemption from preparing a strategic report, in accordance with 414B Companies Act 2006. The Financial statements were approved and authorised for issue by the board and were signed on its behalf on 22 April 2026.
Andrew Watkins
Director
The notes on page 4 form part of these Financial statements. Page 3
INSULSLAB LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025 1.Accounting policies
| 1.1 | Basis of preparation of Financial statements
The Financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The preparation of Financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies. The Company is a dormant Company, as defined by the Companies Act 2006, and has therefore elected to retain its accounting policies for reported assets, liabilities and equity at the date of transition (in accordance with paragraph 35.10 of FRS 102) until there is a change in those balances or the company undertakes any new transactions.
2. | Debtors
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Amounts owed by group undertakings | 1,000 | 1,000
|  | 1,000 | 1,000
3. | Share capital
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
|  | Authorised, allotted, called up and fully paid |  |
|  | 1,000 (2024 - 1,000) Ordinary shares of £1.00 each | 1,000 | 1,000
4. | Controlling party
The Company's immediate parent undertaking is SIG Trading Limited, a Company registered in England and Wales. The Company's ultimate parent undertaking and ultimate controlling party is SIG plc, which is also registered in England and Wales. The only Group in which the Financial statements of the Company are consolidated is that headed by SIG plc. The Consolidated financial statements are available to the public and may be obtained from the Company Secretary of SIG plc at Adsetts House, 16 Europa View, Sheffield Business Park, Sheffield, S9 1XH, or via the Financial statement website www.sigplc.com.
Page 4